John O'Brien

John O'Brien

President and CEO at National Pharmaceutical Council

View articles by John O'Brien

It’s time to stop talking past each other on drug pricing

It’s time to stop talking past each other on…

February 8, 2024

136 likes5 comments

Regarding the NYT's piece on drug pricing

Regarding the NYT's piece on drug pricing

January 19, 2024

120 likes8 comments

Understanding how PBMs operate in the value chain matters for patient access

Understanding how PBMs operate in the value…

August 11, 2023

58 likes5 comments

The value of value assessments

The value of value assessments

May 19, 2023

21 likes

Best ISPOR Ever!

Best ISPOR Ever!

May 10, 2023

71 likes1 comment

Insulin Prices Are Down Because Insulin Makers Have Put Access, Not Theater, First

Insulin Prices Are Down Because Insulin…

May 10, 2023

42 likes1 comment

Net Drug Prices Aren’t Increasing (And It Doesn’t Look Like They Will Anytime Soon)

Net Drug Prices Aren’t Increasing (And It…

May 4, 2023

49 likes1 comment

IRA Implementation Must Value Transparency and Stakeholder Input to Meet Its Goals

IRA Implementation Must Value Transparency…

April 25, 2023

33 likes1 comment

Prioritizing Patients Rather Than Pointing Fingers

Prioritizing Patients Rather Than Pointing…

March 30, 2023

67 likes3 comments

Senate Hearing Shines Spotlight on PBMs & Consumer Benefit

Senate Hearing Shines Spotlight on PBMs &…

February 17, 2023

67 likes5 comments

An Oversimplified Drug Price Policy That Misses the Point

An Oversimplified Drug Price Policy That…

August 11, 2022

110 likes17 comments